A Pilot Trial of Cop 1 in Exacerbating–Remitting Multiple Sclerosis

New England Journal of Medicine

Volumn 317, Issue 7, 1987, Pages 408-414

  Bornstein, Murray B ^a,b   Miller, Aaron ^a,b   Slagle, Susan ^a,b   Weitzman, Muriel ^a,b   Crystal, Howard ^a,b   Drexler, Ellen ^a,b   Keilson, Marshall ^a,b   Merriam, Arnold ^a,b   Wassertheil Smoller, Sylvia ^a,b   Spada, Vincent ^a,b   Weiss, William ^a,b   Arnon, Ruth ^a,b   Jacobsohn, Israel ^a,b   Teitelbaum, Dvora ^a,b   Sela, Michael ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GLATIRAMER; MYELIN BASIC PROTEIN;

ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; THERAPY;

EID: 0023248694     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198708133170703     Document Type: Article

References (28)

1. Teitelbaum D, Meshorer A, Hirshfeld T, Arnon R, Sela M. Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide. Eur J Immunol 1971; 1: 242–8.
2. Webb C, Teitelbaum D, Arnon R, Sela M. In vivo and in vitro immunological cross-reactions between basic encephalitogen and synthetic basic polypeptides capable of suppressing experimental allergic encephalomyelitis. Eur J Immunol 1973; 3: 279–86.
3. Webb C, Teitelbaum D, Herz A, Amon R, Sela M. Molecular requirements involved in suppression of EAE by synthetic basic copolymers of amino acids. Immunochemistry 1976; 13: 333–7.
4. Paterson PY. Experimental allergic encephalomyelitis and autoimmune disease. Adv Immunol 1966; 5: 131–208.
5. Shaw C-M, Alvord EC Jr, Fahlberg WJ, Kies MW. Specificity ofencephalitogen-induced inhibition of experimental “allergic” encephalomyelitis in the guinea pig. I Immunol 1962; 89: 54–61.
6. Teitelbaum D. Webb C, Meshorer A, Arnon R, Sela M. Suppression by several synthetic polypeptides of experimental allergic encephalomyelitis induced in guinea pigs and rabbits with bovine and human basic encephalitogen. Eur J Immunol 1973: 3: 273–9.
7. Arnon R, Teitelbaum D. Desensitization of experimental allergic encephalomyelitis with synthetic peptide analogues. In: Davison AN, Cuzner ML, eds. The suppression of experimental allergic encephalomyelitis and multiple sclerosis. New York: Academic Press, 1980:105–17.
8. Teitelbaum D. Webb C, Bree M, Meshorer A, Arnon R, Sela M. Suppression of experimental allergic encephalomyelitis in rhesus monkeys by a synthetic basic copolymer. Clin Immunol Immunopathol 1974; 3: 256–62.
9. Keith AB, Arnon R, Teitelbaum D, Caspary EA. Wisniewski HM. The effect of Cop 1, a synthetic polypeptide, on chronic relapsing experimental allergic encephalomyelitis in guinea pigs. J Neurol Sci 1979; 42: 267–74.
10. Lando Z, Teitelbaum D, Arnon R. Effect of cyclophosphamide on suppressor cell activity in mice unresponsive to EAE. J Immunol 1979; 123: 2156–60.
11. Arnon R. Experimental allergic encephalomyelitis — susceptibility and suppression. Immunol Rev 1981; 55: 5–30.
12. Raine CS, Snyder DH. Valsamis MP. Stone SH. Chronic experimental allergic encephalomyelitis in inbred guinea pigs: an ultrastructural study. Lab Invest 1974; 31: 369–80.
13. Paterson PY, Day ED. Current perspectives of neuroimmunologic disease: multiple sclerosis and experimental allergic encephalomyelitis. Clin Immunol Rev 1981–82: 1: 581–697.
14. Bomstein MB. The immunopathology of demyelinative disorders examined in organotypic cultures of mammalian central nerve tissues. Prog Neuropathol 1973; 2: 69–90.
15. Bomstein MB, Raine CS. Multiple sclerosis and experimental allergic encephalomyelitis: specific demyelination of CNS in culture. Neuropathol Appl Neurobiol 1977; 3: 359–67.
16. Abramsky O, Teitelbaum D. Amon R, Effect of a synthetic polypeptide (Cop 1) on patients with multiple sclerosis and acute disseminated encephalomyelitis: preliminary report. J Neurol Sci 1977; 31: 433–8.
17. Bomstein MB. Miller AI. Teitelbaum D. Amon R. Sela M. Multiple sclerosis: trial of a synthetic polypeptide. Ann Neurol 1982; 11: 317–9.
18. Barsumian EL. Isersky C. Petrino MG. Siraganian RP. IgE-induced histamine release from rat basophilic leukemia cell lines: isolation of releasing and nonreleasing clones. Eur J Immunol 1981; 11: 317–23.
19. Poser CM, Paty DW. Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227–31.
20. Kurtzke JF. A proposal for a uniform minimal record of disability in multiple sclerosis. Acta Neurol Scand [Suppl] 1981; 87: 110–29.
21. Anderson S. Auquier A. Hauck WW, Oakes D. Vandaele W. Weisberg HI. Statistical methods for comparative studies: techniques for bias reduction. New York: John Wiley. 1980:199–234.
22. Breslow NE, Day NE. Halvorsen KT, Prentice RL. Sabai C. Estimation of multiple relative risk functions in matched case–control studies. Am J Epidemiol 1978; 108: 299–307.
23. Mertin J. Drug treatment of patients with multiple sclerosis. In: Koetsier JC, ed. Handbook of clinical neurology. Vol. 3. Demyelinating diseases. Amsterdam: Elsevier Sciences. 1985:187–212.
24. Lisak RP. Zweiman B. Blanchard N, Rorke LB. Effect of treatment with Copolymer 1 (Cop 1) on the in vivo and in vitro manifestations of experimental allergic encephalomyelitis (EAE). J Neurol Sci 1983; 62: 281–93.
25. Campbell B. Vogel PJ, Fisher E. Lorenz R. Myelin basic protein administration in multiple sclerosis. Arch Neurol 1973; 29: 10–5.
26. Gonsette RE, Delmotte P. Demonty L. Failure of basic protein therapy for multiple sclerosis. J Neurol 1977; 216: 27–31.
27. Salk J, Romine JS, Westall FC, Wiederholt WC. Myelin basic protein studies in experimental allergic encephalomyelitis and multiple sclerosis: a summary with theoretical considerations of multiple sclerosis etiology. In: Davison AN, Cuzner ML, eds. The suppression of experimental allergic encephalomyelitis and multiple sclerosis. New York: Academic Press, 1980:141–56.
28. Burns J, Krasner LJ, Guerrero F. Human cellular immune response to copolymer 1 and myelin basic protein. Neurology 1986; 36: 92–4.